found that the inflammatory microenvironment in ovarian cancer activates the MUC16 gene via the NF-κB pathway, leading to elevated CA125 levels, thereby exacerbating tumor progression and invasiveness (42). This evidence concerns the gene NFKB1 and ovarian carcinoma.